Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2005
12/22/2005US20050282840 Methods of modulating neurotrophin-mediated activity
12/22/2005US20050282836 Solid orally ingestible formulations of tetrodotoxin
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282762 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281885 Method for treating inflammatory bowel disease by oral administration of IL-10
12/22/2005US20050281864 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281807 Use of C-reactive protein to treat immune complex-mediated renal disease
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005CA2569887A1 Pyrrolopyridine derivatives
12/22/2005CA2569836A1 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2569352A1 Morinda citrifolia-based formulation 5-lox and 15-lox
12/22/2005CA2567821A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005CA2566772A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/21/2005EP1607109A1 Multifunctional biodegradable composite and surgical implant comprising said composite
12/21/2005EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606248A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605955A2 Anti-inflammatory composition based on strontium compounds
12/21/2005EP1605946A2 Thiazoles useful as inhibitors of protein kinases
12/21/2005EP1605916A1 Solvent system of hardly soluble drug with improved elution rate
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1402267B1 Chp for use as marker for sepsis
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1278730B1 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1196160B1 A synergistic combination: gabapentin and pregabalin
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005CN1711257A Aryl sulfonamides
12/21/2005CN1711249A Quinazolinone derivatives useful as anti-hyperalgesic agents
12/21/2005CN1711247A Celecoxib prodrug
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232535C GST fusion expression of conotoxin MVII A gene and its use
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232290C Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis
12/21/2005CN1232276C Medicinal liquor for treating arthralgia
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CA2510887A1 A method for treating inflammatory bowel disease by oral administration of il-10
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977261 Treating osteoarthritis or rheumatoid arthritis
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/20/2005CA2092896C Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/15/2005WO2005118559A1 A type of formyl peptide receptor-like 1 regulator, preparation method and use thereof
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117860A1 Method of treating and preventing arthritis, cutaneous and cardiovascular inflammatory-related diseases using nicotinic receptor agonists
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005WO2004066931A3 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
12/15/2005WO2003062370A3 Multimeric proteins and methods of making and using same
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277687 synergistic mixture of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol (Tapentadol) with celecoxib or rofecoxib; enantiomer; racemic mixture; smaller dosages so fewer side effects
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277674 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277617 Comprises an amino sugar and trehalose
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050277603 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276847 Oral delivery system
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/15/2005DE102004025791A1 Chromanol-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Chromanol derivatives, a process for their preparation and their use as anti-inflammatories
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2569155A1 Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
12/15/2005CA2568524A1 Modulators of muscarinic receptors
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 1272